Table 1 Nonleukemic MS in the small intestine: summary of studies in the English-language literature
From: Isolated myeloid sarcoma presenting with small bowel obstruction: a case report
Study | Age/sex | Chief complaint | No. of tumors | First diagnosis | Treatment modality | Outcome |
|---|---|---|---|---|---|---|
Wang et al. [11] | 25/M | Abdominal distension | 4 | MS | Surgery | Developed AML after 3 months |
Cicilet et al. [12] | 45/F | Abdominal pain and vomiting | 1 | MS | Not described | Not described |
Hotta and Kunieda [13] | 56/M | Vomiting | 1 | GS | Surgery and chemotherapy for AML | 54 months, alive without recurrence |
McKenna et al. [14] | 49/F | Abdominal pain | 1 | MS | Surgery and chemotherapy for AML | 2 years, alive without recurrence |
Palanivelu et al. [15] | 52/M | Abdominal distension and pain | 1 | GS | Surgery | 14 months, alive without recurrence |
Kumar et al. [16] | 55/F | Abdominal pain and vomiting | 1 | GS | Surgery and chemotherapy for AML | Not described |
Yoldaş et al. [17] | 44/M | Abdominal pain, distension, nausea, and vomiting | 1 | MS | Surgery and chemotherapy | 9 postoperative months, alive without recurrence |
Kwan et al. [18] | 39/F | Nausea, vomiting, diarrhea, abdominal pain | 1 | Crohn's disease | Surgery, steroid therapy, and chemotherapy for AML | 2 years, alive without recurrence |
Wong et al. [19] | 36/M | Abdominal pain | 1 | GS | Surgery and chemotherapy for AML | 1 postoperative year, alive without recurrence |
Ioannidis et al. [20] | 48/M | Epigastric pain, distension, vomiting | 1 | MS | Surgery and AML chemotherapy | 6 months, alive without recurrence |
Lim et al. [21] | 55/M | Abdominal fullness and dyspepsia | 2 | MS | Not described | Not described |
Lee et al. [22] | 45/M | Abdominal pain | 8 | GS | Surgery and chemotherapy for AML | 12 months, alive without recurrence |
Kitagawa et al. [2] | 33/F | Abdominal pain and vomiting | 2 | GS | Surgery and chemotherapy for AML and BMT | 57 months, alive without recurrence |
Mrad et al. [23] | 13/F | Abdominal mass | 2 | MS | Surgery and chemotherapy for AML | 27 months, alive without recurrence |
McCusker et al. [24] | 22/F | Abdominal pain | 2 | Large-cell lymphoma | Surgery, CHOP therapy, and chemotherapy for AML and BMT | 13 months, alive without recurrence |
Kim et al. [25] | 49/M | Abdominal pain | 5 | MS | Surgery | Died |
Gajendra et al. [26] | 35/M | Abdominal pain | 3 | T-cell lymphoma | Surgery | Developing AML after 1 month |
Jung et al. [27] | 48/M | Abdominal discomfort | Not countable | GS | Surgery, chemotherapy for AML and BMT | 6 Months, alive without recurrence |